IRIS
BUCCI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.257
EU - Europa 5.244
AS - Asia 4.164
SA - Sud America 423
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 6
Totale 16.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.143
SG - Singapore 1.793
IT - Italia 1.390
CN - Cina 1.106
IE - Irlanda 581
DE - Germania 527
SE - Svezia 492
UA - Ucraina 485
FR - Francia 462
RU - Federazione Russa 461
VN - Vietnam 397
GB - Regno Unito 378
TR - Turchia 342
BR - Brasile 339
FI - Finlandia 204
IN - India 203
HK - Hong Kong 92
CA - Canada 64
PL - Polonia 54
ES - Italia 41
MX - Messico 38
NL - Olanda 38
AR - Argentina 36
BD - Bangladesh 34
JP - Giappone 29
BE - Belgio 26
ZA - Sudafrica 24
ID - Indonesia 22
MY - Malesia 20
IQ - Iraq 19
AT - Austria 18
EC - Ecuador 17
KR - Corea 15
IL - Israele 13
IR - Iran 13
CH - Svizzera 12
LT - Lituania 12
PK - Pakistan 12
EG - Egitto 11
VE - Venezuela 11
GR - Grecia 10
CZ - Repubblica Ceca 9
TH - Thailandia 9
EU - Europa 8
KE - Kenya 8
SA - Arabia Saudita 8
AL - Albania 7
UZ - Uzbekistan 7
CO - Colombia 6
ET - Etiopia 6
PH - Filippine 6
AU - Australia 5
MA - Marocco 5
PT - Portogallo 5
PY - Paraguay 5
SI - Slovenia 5
CL - Cile 4
DK - Danimarca 4
EE - Estonia 4
LB - Libano 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
JM - Giamaica 3
KZ - Kazakistan 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
MC - Monaco 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
SL - Sierra Leone 1
Totale 16.171
Salva come PNG Salva come JPEG
Città #
Singapore 1.301
Chandler 720
San Jose 698
Jacksonville 568
Dublin 562
Ashburn 462
Dallas 386
Beijing 304
Munich 289
Princeton 254
Southend 222
Izmir 197
Los Angeles 190
The Dalles 163
New York 158
Nanjing 157
Ho Chi Minh City 136
Santa Clara 133
Ann Arbor 119
Wilmington 111
Pescara 107
Helsinki 104
Hanoi 98
Dearborn 97
Cambridge 93
Chieti 92
Milan 88
Hong Kong 75
Boardman 72
Tongling 70
Nanchang 63
Altamura 62
Rome 59
Moscow 53
São Paulo 50
Houston 46
Buffalo 44
Orem 43
Woodbridge 40
Redondo Beach 38
Council Bluffs 37
Shenyang 35
Warsaw 32
Denver 31
Hebei 31
Tianjin 31
Foggia 30
Washington 30
Brooklyn 29
Hefei 27
Da Nang 26
Chennai 25
London 25
Nuremberg 25
Tokyo 25
Brussels 24
Jinan 23
Frankfurt am Main 22
Montreal 22
Chicago 21
Phoenix 21
Toronto 20
Atlanta 19
Boston 19
Haiphong 19
Kunming 19
Poplar 19
Stockholm 19
Amsterdam 17
Florence 17
Mexico City 17
Norwalk 17
Bologna 16
Johannesburg 16
Manchester 16
Zhengzhou 16
Turku 15
Grevenbroich 14
Hangzhou 14
Rio de Janeiro 14
Biên Hòa 13
Ningbo 13
Auburn Hills 12
Changsha 12
Jiaxing 12
Mumbai 12
Naples 12
Orange 12
Seattle 12
Guangzhou 11
Seoul 11
Kraków 10
San Francisco 10
San Mateo 10
Taizhou 10
Ankara 9
Bari 9
Charlotte 9
Avellino 8
Brno 8
Totale 9.634
Salva come PNG Salva come JPEG
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 552
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 306
MicroRNA profiling in migraine without aura: Pilot study 253
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 250
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 219
A unique microRNA signature associated with plaque instability in humans. 206
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 180
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 171
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 165
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 165
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 165
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 163
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 162
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 162
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 161
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 160
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 160
Uneven accuracy of home blood pressure measurement: a multi-centric survey 159
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 155
A unique microRNA signature associated with ischemic stroke in humans 154
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 154
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 151
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 151
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 144
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 144
Ipertensione arteriosa ed algosensibilità muscolare 142
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 140
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 139
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 139
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 139
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 138
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 137
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 136
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 136
Association between 5-lipoxygenase expression and plaque instability in humans. 135
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 134
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 133
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 133
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 131
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 130
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 130
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 128
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 128
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 128
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 127
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 127
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 127
COVID-19 and RAS: Unravelling an Unclear Relationship 127
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 125
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 125
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 125
The (K+)ey of the problem 124
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 123
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 123
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 123
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 123
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 122
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 121
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 121
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 120
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 120
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 119
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 118
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 118
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 118
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 118
Impact of hypertension on somatic pain sensitivity in chronic headache 117
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 115
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 115
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 113
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia 113
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 112
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 112
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 112
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 112
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 111
Cardiovascular risk awareness: what does patient feel? 109
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 108
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 108
Muscle pain sensitivity in hypertensive patients with and without chronic pain 108
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 105
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 105
Hypertension modulates miR-145 expression in human atherosclerotic plaques 105
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 104
Possible indication of coronary risk trough discriminant functions. 103
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 103
Long-term positivity to SARS-Cov-2: a clinical case of Covid-19 with persistent evidence of infection 103
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 101
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 101
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 101
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 99
Effect of evolocumab or ezetimibe added to moderate- Or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: The LAPLACE-2 randomized clinical trial 99
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 99
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 98
A drug induced autoimmune hemolytic anemia: a case report. 97
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 97
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 96
When a timely diagnosis means life: a precious lesson from a clinical case 96
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 96
An atypical etiology of ARDS: the importance of a careful eye in the evaluation. 95
Totale 13.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.819
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.786 133 449 356 74 103 144 217 159 356 145 302 348
2025/20265.334 491 232 625 708 568 349 952 297 559 446 107 0
Totale 16.663